Skip to content

Identification and application of qualitative transcriptional signatures for pathological diagnosis of breast cancer

Identification and application of qualitative transcriptional signatures for pathological diagnosis of breast cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055502
Enrollment
Unknown
Registered
2022-01-11
Start date
2022-01-11
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:Consistent pathological diagnosis of three pathologists.
Index test:Qualitative&#32
criptional&#32
signatures&#32
consisting&#32
of&#32
gene&#32
pairs&#32
for&#32
diagnosis&#32
ER,&#32
PR,&#32
Ki67&#32
and&#32
Histology&#32
Grade.

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Subjects with invasive breast cancer; 2. Female, aged >= 18 years; 3. Signed informed consent; 4. With complete pathological diagnosis information, pathological diagnosis including ER, PR, HER2, Ki67 and Histology Grade.

Exclusion criteria

Exclusion criteria: 1. Before sampling, subjects were complicated with other malignancy or series diseases; 2. Subjects had received medical treatment before; 3. Subjects with metastatic or recurrent tumors.

Design outcomes

Secondary

MeasureTime frame
Recurrence-free survival;Overall survival;

Primary

MeasureTime frame
Accuracy;Sensitivity;Specificity;F-score;

Countries

China

Contacts

Public ContactCai Hao

The First Affiliated Hospital of Gannan Medical University

caihao093@163.com+86 13375003926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026